- Home
- VALN vs STK Comparison
VALN vs STK Comparison
Compare VALN & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- STK
- Stock Information
- Founded
- VALN 2012
- STK 2009
- Country
- VALN France
- STK United States
- Employees
- VALN N/A
- STK N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- STK Investment Managers
- Sector
- VALN Health Care
- STK Finance
- Exchange
- VALN Nasdaq
- STK Nasdaq
- Market Cap
- VALN 510.7M
- STK 545.8M
- IPO Year
- VALN 2021
- STK N/A
- Fundamental
- Price
- VALN $6.79
- STK $26.08
- Analyst Decision
- VALN Strong Buy
- STK
- Analyst Count
- VALN 2
- STK 0
- Target Price
- VALN $16.00
- STK N/A
- AVG Volume (30 Days)
- VALN 142.9K
- STK 38.2K
- Earning Date
- VALN 05-06-2025
- STK 01-01-0001
- Dividend Yield
- VALN N/A
- STK 6.60%
- EPS Growth
- VALN N/A
- STK N/A
- EPS
- VALN N/A
- STK N/A
- Revenue
- VALN $175,564,758.00
- STK N/A
- Revenue This Year
- VALN $19.17
- STK N/A
- Revenue Next Year
- VALN $26.31
- STK N/A
- P/E Ratio
- VALN N/A
- STK N/A
- Revenue Growth
- VALN 10.32
- STK N/A
- 52 Week Low
- VALN $3.62
- STK $24.95
- 52 Week High
- VALN $9.50
- STK $34.31
- Technical
- Relative Strength Index (RSI)
- VALN 50.63
- STK 37.04
- Support Level
- VALN $6.54
- STK $25.84
- Resistance Level
- VALN $7.30
- STK $27.55
- Average True Range (ATR)
- VALN 0.48
- STK 1.12
- MACD
- VALN 0.01
- STK 0.07
- Stochastic Oscillator
- VALN 56.79
- STK 55.80
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.